Literature DB >> 3622313

Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.

N Rehnqvist, G Nyberg, P Carlens, E Lindström, T Lundman, R Nordlander, G Ulvenstam, A Aberg, H Aström.   

Abstract

This article reviews the results of double-blind comparative studies on the therapeutic use of isosorbide 5-mononitrate as monotherapy in the prophylaxis of angina pectoris. Isosorbide 5-mononitrate appears at least as effective as the same dosage of isosorbide dinitrate and is probably superior to the calcium antagonists. Recent data have shown that isosorbide 5-mononitrate in a controlled-release formulation given once daily has a significantly better antianginal effect than placebo without inducing the development of tolerance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622313     DOI: 10.2165/00003495-198700334-00018

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  3 in total

1.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

2.  [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].

Authors:  U Abshagen; S Spörl-Radun; G Betzien; B Kaufmann; R Endele
Journal:  Med Welt       Date:  1981-04-07

3.  The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study.

Authors:  G Nyberg; P Carlens; E Lindström; T Lundman; R Nordlander; N Rehnqvist; G Ulvenstam; A Aberg; H Aström
Journal:  Eur Heart J       Date:  1986-10       Impact factor: 29.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.